Showing posts with label
NTLA
.
Show all posts
Showing posts with label
NTLA
.
Show all posts
Tuesday, November 17, 2026
An Alternative to an Uncertain AI Trade - medicine and, in particular, Genetics
›
Investment Note: Gene editing in focus Why I like BEAM, CRSP and NTLA The Next Medical Revolution — and an Alternative to an Uncertain AI...
Thursday, August 28, 2025
BEAM Therapeutics - A simplified investor report!
›
Beam Therapeutics (NASDAQ: BEAM) Simplified Investor Report – August 2025 1. What Beam Does Beam is a gene-editing company that uses ...
Monday, August 25, 2025
Intellia Therapeutics (NTLA) — Investor Brief (Aug 2025) - A leader in Crispr/Gene editing advancements!
›
As NTLA's phase 3 trials continue to show signs of real breakthroughs, there may eventually be takeover offers. (Speculation) Full dis...
Friday, July 25, 2025
Why are the analysts covering Arcturus Therapeutics so bullish on this stock - ARCT in BioTech!
›
Why Are Analysts So Bullish on ARCT? (Update Aug 4th) ✅ 1. Universally Strong Analyst Ratings Nearly all analysts currently rate ARCT ...
›
Home
View web version